In my practice I have seen patients make similar gains to semaglutide, even while staying on lower doses of tirzepatide
Author Contributions Concept and design: Kristina Nazzicone, Ashley O'Toole Acquisition, analysis, or interpretation of data: Kristina Nazzicone, Ashley O'Toole, Michael Sidiropoulos Drafting of the manuscript: Kristina Nazzicone Critical review of the manuscript for important intellectual content: Ashley O'Toole, Michael Sidiropoulos Supervision: Ashley O'Toole References 1.Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
Note: Data are from the on-treatment period
This scoping review identifies the evidence regarding the benefits and risks of the combined use of GLP1-RAs and SGLT2is in individuals with T2D
Dosing schedules: Ozempic dosing typically begins at 0.25 mg weekly for four weeks (an initiation dose, not therapeutic), then increases to 0.5 mg weekly